Results 1 to 5 of 5

The “big bang” for sequence listings: new requirements in place July 1, 2022

USA - May 12 2022 Life sciences patent applications often contain DNA, RNA, and amino acid sequences in the specification, claims, or figures that are required to be…

Dr. Elizabeth (Liz) Newman

Casting a New Light on Diagnostic Patents: “Methods of Preparation” Patent-Eligible

USA - August 12 2020 The ability of life sciences companies to rely on patent protection for diagnostic methods has been eroded over the last ten years, although…

Rachel A. Rice

AI Patent Policy

USA - August 27 2019 On August 26, 2019, Laura Peter, the Deputy Under Secretary of Commerce for Intellectual Property and Deputy Director of the USPTO, posted an update…

Amanda Elisabeth Casale, Anna Yuan

Patent Eligibility in the Life Sciences: Supreme Court Declines Review of Ariosa Diagnostics v. Sequenom

USA - June 30 2016 On June 27, 2016, the U.S. Supreme Court denied certiorari in Ariosa Diagnostics, Inc. v. Sequenom, Inc., thereby letting stand the Federal Circuit's…

James J. Mullen, III

USPTO Issues New Subject Matter Eligibility Examples for Life Sciences

USA - May 12 2016 The United States Patent and Trademark Office (USPTO) recently provided updated guidance regarding the patent eligibility of subject matter related…

James J. Mullen, III, Amanda T. White